Workflow
Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings

We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the worst-performing stocks on Wednesday. Soleno Therapeutics extended its losing streak to a 5th consecutive day on Wednesday, slashing 26.59 percent to close at $46.87 apiece as investors appeared to have priced in a strong earnings performance in the third quarter of the year. The maker of the first and only FDA-approved drug for hyperphagia said in an updated report that it swung to a ...